Antimicrobials
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
94
NCT02737722
Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus
Phase: Phase 1/2
Role: Lead Sponsor
Start: Apr 30, 2016
Completion: Feb 28, 2018
NCT05276401
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
Phase: Phase 2
Start: Mar 11, 2022
Completion: Jun 15, 2022
NCT06020235
Nu-3 Gel for Infected Diabetic Foot Ulcers
Start: Dec 31, 2025
Completion: Aug 31, 2026
Loading map...